NCT07537348 2026-04-17
LUCENT-GC-03
Qilu Hospital of Shandong University
Phase 2 Recruiting
Clinical Trials
41 trialsNCT07294664 2026-04-16
PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer
The First Affiliated Hospital of Zhengzhou University
Phase 2 Recruiting
NCT07486310 2026-03-20
Evaluation of Pressurized Intraperitoneal Aerosol Chemotherapy With VRT106 Versus PIPAC in Patients With Advanced Gastric Cancer and PeritonealMetastasis: A Prospective, Multicenter, Open-Label, Randomized Controlled Trial
Guangdong Provincial People's Hospital
Phase 2 Not yet recruiting
NCT07298200 2026-02-25
Clinical Trial on the Safety, Tolerance and Preliminary Efficacy of XH001 Injection Combined With Neoantigen Vaccine-induced Tumor-specific T-cell Injection in Advanced Gastric Cancer
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School
Phase 1 Recruiting
NCT07371871 2026-01-28
A Prospective, Single-arm, Exploratory Study of Trifluridine/Tipiracil (TAS-102) Combined With Apatinib as Third-line Therapy for Advanced Gastric Cancer
Anhui Provincial Cancer Hospital
Phase NA Not yet recruiting
NCT06346093 2025-06-10
Fecal Microbiota Transplantation (FMT) in Patients With Advanced Gastric Cancer
Changhai Hospital
Phase NA Recruiting
NCT02142322 2025-04-17
Perioperative mFOLFOX-6 in Locally Advanced Gastric Cancer
Seoul National University Hospital
Phase 2 Completed
NCT04195828 2025-04-01
Camrelizumab Combined with Apatinib Mesylate Tablets, Nab-paclitaxel and S-1 in the Treatment of Locally Advanced Gastric Cancer
Fujian Medical University
Phase 2 Completed
NCT06706895 2024-11-27
A Single-arm, Single-center Phase II Clinical Study on the Clinical Efficacy and Safety of Paclitaxel Polymeric Micelles for Injection Combined With Fruquintinib Capsules in the Second-line Treatment of Patients With Advanced Gastric Cancer
Shanghai Zhongshan Hospital
Phase 2 Not yet recruiting
NCT06592287 2024-09-19
The Combination of Adebrelimab, Apatinib, and Lrinotecan Liposome for Second-line Treatment of Advanced Gastric Cancer
Huazhong University of Science and Technology
Phase 1/2 Not yet recruiting
NCT06432075 2024-05-29
Neoantigen Reactive T Cells c for Chinese Patients With Advanced Gastric Cancer
First Affiliated Hospital of Wenzhou Medical University
Phase EARLY_PHASE1 Not yet recruiting
NCT03579784 2024-04-19
Biomarker-oriented Study of Durvalumab (MEDI4736) in Combination With Olaparib and Paclitaxel in Gastric Cancer
Seoul National University Hospital
Phase 2 Active not recruiting
NCT06169410 2024-01-23
Ramucirumab Combined With Nab-paclitaxel, Lobaplatin, and S-1 in Neoadjuvant Transformation Therapy for Advanced Gastric Cancer
Xijing Hospital
Phase 4 Unknown
NCT05584592 2022-10-18
A Randomized Controlled Trial of Integrated Early Palliative Care for Advanced Gastric Cancer Patients
Yonsei University
Phase NA Unknown
NCT04890392 2021-08-12
Tislelizumab Combined With S-1 Plus Oxaliplatin as a Neoadjuvant Treatment in Patients With GC/GEJC
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology
Phase 2 Unknown
NCT04286711 2020-02-27
Clinical Study of Albumin-paclitaxel Combined With Apatinib and Camrelizumab in Advanced Gastric Cancer
China Medical University, China
Phase 1/2 Unknown
NCT00915382 2020-01-07
Trial of 3-weekly Versus 5-weekly Schedule of S-1 Plus Cisplatin in Gastric Cancer: SOS
Asan Medical Center
Phase 3 Completed
NCT00976768 2020-01-07
Biweekly FOLFIRI in Advanced Gastric Cancer (AGC) With Failure of Prior Taxane, Fluoropyrimidine, and Cisplatin
Asan Medical Center
Phase 2 Completed
NCT01049620 2020-01-07
RAD001 in Combination With Capecitabine and Oxaliplatin (XELOX) in Patients With Advanced Gastric Cancer: RAD001+XELOX
Asan Medical Center
Phase 1 Completed
NCT01471470 2020-01-07
Efficacy of Docetaxel, Capecitabine, Cisplatin, and Bevacizumab in Patients With Unresectable Advanced Gastric Cancer
Asan Medical Center
Phase 2 Completed
NCT02451956 2019-12-30
Study of AZD5363 in Combination With Paclitaxel, in Advanced Gastric Adenocarcinoma Patients Harboring PIK3CA Mutation and/or PIK3CA Amplification as a Second-line Chemotherapy
Samsung Medical Center
Phase 2 Completed
NCT04182724 2019-12-03
Camrelizumab, Apatinib and Nab-paclitaxel as Second-line Treatment in Advanced Gastric Cancer
Chinese PLA General Hospital
Phase 1/2 Unknown
NCT01503372 2019-02-12
PaFLO
Charite University, Berlin, Germany
Phase 2 Completed
NCT03350477 2019-01-25
Bioinformation Therapy for Gastric Cancer
Fuda Cancer Hospital, Guangzhou
Phase 2/3 Completed
NCT03449966 2019-01-11
Comparison of Ability of pCLE and WLE for Diagnosis and Cancer Tissue Acquisition in Advanced Gastric Cancer After Chemotherapy Status
Yonsei University
Phase NA Unknown
NCT03564834 2018-09-28
Laparoscopic Versus Open Gastrectomy for Elderly Local Advanced Gastric Cancer Patients
Peking University
Phase 2 Unknown
NCT03255811 2017-08-21
Clinical Study on Treatment of Apatinib Mesylate in First-line Maintenance of Advanced Gastric Cancer
Guangdong Provincial People's Hospital
Phase NA Unknown
NCT01441336 2017-01-09
Laparoscopic Gastrectomy for Advanced Gastric Cancer
Seoul National University Bundang Hospital
Phase 2 Completed
NCT01152853 2015-11-20
PF299804-AGC
Seoul National University Hospital
Phase 2 Completed
NCT01136031 2015-05-20
TI-2ndAGC
Seoul National University Hospital
Phase 1/2 Completed
NCT00842491 2015-05-19
Study of Endostar With Cisplatin and Capecitabine as 1st Line Treatment in the Advanced Gastric Cancer
Peking University
Phase 2 Completed
NCT01015339 2015-05-19
Paclitaxel Plus Capecitabine With Capecitabine Maintenance Treatment in Metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
Peking University
Phase 3 Unknown
NCT02123407 2014-04-25
Clinical Study on the Harvesting Lymph Nodes With Carbon Nanoparticles for Advanced Gastric Cancer
Peking University
Phase 3 Unknown
NCT02072317 2014-02-26
Paclitaxel Plus Raltitrexed Plug Compare With Taxol Second-line Treatment for Advanced Gastric Cancer
Fudan University
Phase 2 Unknown
NCT02071043 2014-02-25
Trial of Xeloda and Oxaliplatin (XELOX) as Neo-adjuvant Chemotherapy Followed by Surgery in Advanced Gastric Cancer Patients With Para-aortic Lymph Node Metastasis
Shanghai Zhongshan Hospital
Phase 2 Completed
NCT02038621 2014-01-16
GZH-001
The Second People's Hospital of Sichuan
Phase 2 Unknown
NCT01851941 2013-05-13
A Phase II Trial of Perioperative Chemotherapy With Oxaliplatin, 5-Fluorouracil, Leucovorin(MODIFIED FOLFOX6) in Patients With Locally Advanced Operable Gastric Cancer
Seoul National University Hospital
Phase 2 Completed
NCT01238055 2013-04-09
Sunitinib + Docetaxel as Second-line Treatment in Gastric Cancer
Samsung Medical Center
Phase 2 Completed
NCT00821990 2012-01-20
Second-line Therapy Versus Supportive Care for Pretreated Advanced Gastric Cancer
Samsung Medical Center
Phase 3 Completed
NCT00992199 2010-09-08
IPchemo-AGC
Fudan University
Phase 2 Unknown
NCT00743964 2010-01-15
Phase II Study of Epirubicin, Cisplatin and Capecitabine (ECX) Versus Cisplatin and Capecitabine (CX) for Advanced Gastric Cancer (AGC)
Samsung Medical Center
Phase 2 Completed